Skip to content
#45 of 175APUS:USπŸ‡ΊπŸ‡Έ United States

Apimeds Pharmaceuticals US Inc

Apimeds Pharmaceuticals US Inc holds 1,000 BTC, the #45 largest public-company Bitcoin treasury tracked by Perception. That's 0.1% of all corporate Bitcoin holdings and 0.005% of total supply.

Bitcoin Held
1,000
β‰ˆ $63.3M at $63,286/BTC
BTC Held
1,000
Rank #45 of 175
Current Value
$63.3M
at $63,286/BTC
Avg Cost Basis
β€”
not disclosed
Unrealized P&L
β€”
Cost basis not disclosed

Where Apimeds Pharmaceuticals US Inc ranks

Share of all corporate BTC
0.1%
Share of total BTC supply
0.005%

Public companies hold 1,285,045 BTC in aggregate ($81.32B), about 6.12% of Bitcoin's circulating supply. Apimeds Pharmaceuticals US Inc accounts for 0.1% of that.

Narrative vs Capital

Does the coverage lead the buying?

Perception tracks how Apimeds Pharmaceuticals US Inc's media narrative moves against its capital position, showing whether sentiment shifts before the balance sheet does. The full narrative-vs-capital overlay, media coverage, and per-outlet sentiment for Apimeds Pharmaceuticals US Inc live inside Perception.

Data as of
July 17, 2026

Holdings and cost basis from CoinGecko public treasury data. Current value and P&L computed at the live BTC price. Source: Perception Treasury Tracker.

Apimeds Pharmaceuticals US Inc (APUS) Bitcoin Treasury

Apimeds Pharmaceuticals US Inc is the #45 largest public-company Bitcoin holder tracked by Perception, with 1,000 BTC worth approximately $63.3M.

Beyond the balance sheet, Perception tracks Apimeds Pharmaceuticals US Inc's media coverage and sentiment across 1,000+ curated sources, connecting corporate Bitcoin strategy to the narrative around it. Explore the full Bitcoin treasury leaderboard or track Apimeds Pharmaceuticals US Inc in real time on the Perception dashboard.